Ken Griffin Agios Pharmaceuticals, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 30,600 shares of AGIO stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,600
Previous 11,200
173.21%
Holding current value
$1.37 Million
Previous $249,000
259.04%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AGIO
# of Institutions
207Shares Held
60MCall Options Held
365KPut Options Held
457K-
Farallon Capital Management LLC San Francisco, CA5.59MShares$250 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$208 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.01MShares$179 Million1.84% of portfolio
-
State Street Corp Boston, MA3.14MShares$140 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.45B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...